Table 4.
Perceived barriers to implementation of photoprotection practices in patients with malignant melanoma, those with atypical mole syndrome, and controls
|
|
Patients with a PMH of MM, n = 26
|
Patients with AMS, n = 47
|
Control group, n = 48
|
All participants, n = 121
|
P
value
|
| Have any of the following barriers discouraged you from practicing sun protection? n (%) | |||||
| No | 7/26 (26.9%) | 27/47 (57.4%) | 24/48 (50%) | 58/121 (47.9%) | 0.656 |
| Yes | 19/26 (73.1%) | 20/47 (42.6%) | 24/48 (50%) | 63/121 (52.1%) | |
| Skepticism (“I do not believe skin cancer is a serious health threat”), n (%) | |||||
| No | 22/26 (84.6%) | 43/47 (91.5%) | 45/48 (93.8%) | 110/121 (90.9%) | 0568 |
| Yes | 4/26 (15.4%) | 4/47 (8.5%) | 3/48 (6.3%) | 11/121 (9.1%) | |
| Hassle/lack of time, n (%) | |||||
| No | 21/26 (80.8%) | 35/47 (74.5%) | 38/48 (79.2%) | 94/121 (77.7%) | 0.639 |
| Yes | 5/26 (19.2%) | 12/47 (25.5%) | 10/48 (20.8%) | 27/121 (22.3%) | |
| Concerns over adequate Vitamin D, n (%) | |||||
| No | 20/26 (76.9%) | 34/47 (72.3%) | 32/48 (66.7%) | 86/121 (71.1%) | 0.486 |
| Yes | 6/26 (23.1%) | 13/47 (27.7%) | 16/48 (33.3%) | 35/121 (28.9%) | |
| Cost/financial concerns. n (%) | |||||
| No | 25/26 (96.2%) | 38/47 (80.9%) | 39/48 (81.3%) | 102/121 (84.3%) | 0.810 |
| Yes | 1/26 (3.8%) | 9/47 (19.1%) | 9/48 (18.8%) | 19/121 (15.7%) | |
| Appearance (“I do not like how using sun protection will make me look”), n (%) | |||||
| No | 24/26 (92.3%) | 44/47 (93.6%) | 48/48 (100%) | 116/121 (95.9%) | 0.090 |
| Yes | 2/26 (7.7%) | 3/47 (6.4%) | 0/48 (0%) | 5/121 (4.1%) | |
| Difficulty obtaining materials (sunscreen, sunglasses, hats, etc), n (%) | |||||
| No | 25/26 (96.2%) | 44/47 (93.6%) | 114/121 (94.2%) | 0.962 | |
| Yes | 1/26 (3.8%) | 3/47 (6.4%) | 7/121 (5.8%) | ||
| Sunscreen is uncomfortable or unpleasant, n (%) | |||||
| No | 22/26 (84.6%) | 43/48 (91.5%) | 47/48 (97.9%) | 112/121 (93%) | 0.149 |
| Yes | 4/26 (15.4%) | 4/48 (8.5%) | 1/48 (2.1%) | 9/121 (7%) | |
| Previous “bad” reaction to sunscreen (please specify), n (%) | |||||
| No | 25/26 (96.2%) | 47/47 (100%) | 48/48 (100%) | 120/121 (99.2%) | 0.765 |
| Yes | 1/26 (3.8%) | 0/47 (0%) | 0/48 (0%) | 1/121 (0.8%) | |
| None/no barriers have discouraged me, n (%) | |||||
| No | 14/26 (53.8%) | 21/121 (44.7%) | 23/48 (47.9%) | 58/121 (47.9%) | 0.840 |
| Yes | 12/26 (46.2%) | 26/121 (55.3%) | 25/48 (52.1% | 63/121 (52.1%) |
PMH: Past medical history; MM: Malignant melanoma; AMS: Atypical mole syndrome.